Evidence map›Paper›PMID 29526930›Full record

ArticleInternal medicine (Tokyo, Japan)2018

Five Cases of Familial Mediterranean Fever in Japan: The Relationship with MEFV Mutations.

Kazuki Kimura, Masafumi Mizooka, Kiyoshi Migita, Ryoko Ishida, Masatoshi Matsumoto, Satoshi Yamasaki, Nobusuke Kishikawa, Akihiro Kawahara, Yuka Kikuchi, Yuichiro Otani and 9 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Kazuki KimuraDepartment of Community Based Medical System, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Masafumi MizookaDepartment of General Internal Medicine, Hiroshima University Hospital, Japan.
Kiyoshi MigitaDepartment of Rheumatology, Fukushima Medical University School of Medicine, Japan.
Ryoko IshidaDepartment of Community Based Medical System, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Masatoshi MatsumotoDepartment of Community Based Medical System, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan.
Satoshi YamasakiDivision of Rheumatology, Kurume University Medical Center, Japan.
Nobusuke KishikawaDepartment of General Internal Medicine, Hiroshima University Hospital, Japan.
Akihiro KawaharaDepartment of General Internal Medicine, Hiroshima University Hospital, Japan.
Yuka KikuchiDepartment of General Internal Medicine, Hiroshima University Hospital, Japan.
Yuichiro OtaniDepartment of General Internal Medicine, Hiroshima University Hospital, Japan.
Tomoki KobayashiDepartment of General Internal Medicine, Hiroshima University Hospital, Japan.
Daisuke MiyamoriDepartment of General Internal Medicine, Hiroshima University Hospital, Japan.
Takuya IkutaDepartment of General Internal Medicine, Hiroshima-Nishi Medical Center, Japan.
Hiroshi NakamuraDepartment of General Internal Medicine, Hiroshima-Nishi Medical Center, Japan.
Kenichi YokobayashiDepartment of General Internal Medicine, Hiroshima University Hospital, Japan.
Shuichi IwamotoDepartment of General Internal Medicine, Hiroshima University Hospital, Japan.
Keishi KannoDepartment of General Internal Medicine, Hiroshima University Hospital, Japan.
Hiromasa OhiraDepartment of Gastroenterology, Fukushima Medical University School of Medicine, Japan.
Susumu TazumaDepartment of General Internal Medicine, Hiroshima University Hospital, Japan.
Hiroshima University Hospital · JPFukushima Medical University · JPHiroshima University · JPKobe Medical Center · JPKurume University Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Familial Mediterranean fever (FMF) is the most common genetic autoinflammatory disease, but it has been considered a rare disease in Japan. We herein describe five patients with FMF who were diagnosed both clinically and genetically at a single Japanese institute. A genetic investigation of Mediterranean fever (MEFV) detected heterozygosity for the compound mutations L110P/E148Q (n=2) and L110P/148Q/P369S/R406Q (n=1), and heterozygosity for M694I (n=1) and S503C (n=1). Colchicine prevented febrile attacks and accompanying symptoms in four patients. One patient with an S503C mutation showed resistance. Physicians should be aware of the characteristic symptoms, as well as the more unusual symptoms such as headache, when diagnosing FMF.

Indexed as

AdultAsian PeopleColchicineCytoskeletal ProteinsFamilial Mediterranean FeverFemaleHeterozygoteHumansJapanMaleMiddle AgedMutationPyrinRare DiseasesTreatment OutcomeColchicineCytoskeletal ProteinsMEFV protein, humanPyrinaseptic meningitisfamilial Mediterranean feverheadacheinflammatory diseaseJapanperiodic fever

Identifiers

PMID29526930
PMCPMC6148168
OpenAlexW2793432212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.